01:19 , Oct 6, 2018 |  BioCentury  |  Finance

In sight of uncharted territory

Strong growth from small- and mid-caps coupled with a late run from large cap biotechs has pushed the sector within sight of its all-time high in 2015. Some buysiders now are seeing red flags of...
19:51 , Oct 5, 2018 |  BC Week In Review  |  Financial News

Aldeyra, Nightstar price follow-ons

Aldeyra Therapeutics Inc. (NASDAQ:ALDX) and Nightstar Therapeutics plc (NASDAQ:NITE) each priced follow-ons Sept. 27, raising a total of about $144 million. Aldeyra raised $72.2 million through the sale of 5.3 million shares at $13.75 in...
21:25 , Sep 28, 2018 |  BC Extra  |  Financial News

Aldeyra, Nightstar price follow-ons

Aldeyra Therapeutics Inc. (NASDAQ:ALDX) and Nightstar Therapeutics plc (NASDAQ:NITE) each priced follow-ons Thursday, raising a total of about $144 million. Aldeyra raised $72.2 million through the sale of 5.3 million shares at $13.75 in a...
16:26 , Jan 26, 2018 |  BC Week In Review  |  Financial News

Arrowhead raises $60.4M follow-on

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) raised $60.4 million through the sale of 11.5 million shares at $5.25 in a follow-on, including a 1.5 million share overallotment, on Jan. 22. Jefferies, Barclays Capital, Cantor Fitzgerald, Chardan...
12:26 , May 26, 2017 |  BC Week In Review  |  Financial News

Alnylam raises $359.4M in follow-on

RNAi therapeutics company Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) raised $359.4 million on May 24 through the sale of 5 million shares at $71.87 in a follow-on underwritten by Barclays Capital. Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), Cambridge, Mass. ...
22:53 , May 24, 2017 |  BC Extra  |  Financial News

Follow-on roundup: Alnylam, GlycoMimetics, Albireo

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), GlycoMimetics Inc. (NASDAQ:GLYC) and Albireo Pharma Inc. (NASDAQ:ALBO) all priced follow-ons Wednesday, raising a combined $485 million. Alnylam raised $359.4 million via the sale of 5 million shares at $71.87 in...
01:37 , May 5, 2017 |  BC Week In Review  |  Financial News

Aratana proposes $24.4M follow-on

On May 4, animal health company Aratana Therapeutics Inc. (NASDAQ:PETX) proposed to raise $24.4 million through the sale of 5 million shares at $5.25 in a follow-on underwritten by Barclays Capital. Aratana Therapeutics Inc. (NASDAQ:PETX),...
21:07 , Jan 27, 2017 |  BC Week In Review  |  Financial News

Cascadian Therapeutics completes follow-on

Cancer company Cascadian Therapeutics Inc. (NASDAQ:CASC) raised $82.5 million through the sale of 23.2 million shares at $3.30 and 1,818 shares of series E convertible preferred stock at $3,300 in concurrent underwritten offerings on Jan....
07:00 , Oct 31, 2016 |  BC Week In Review  |  Financial News

Myovant completes IPO

Myovant Sciences Ltd. (NYSE:MYOV), Hamilton, Bermuda  Business: Genitourinary, Cancer, Endocrine/Metabolic  Date completed: 2016-10-27  Type: IPO  Raised: $217.5 million  Shares: 14.5 million  Price: $15  Shares after offering: 60 million  Underwriters: Citigroup; Cowen; Evercore; Barclays Capital; JMP...
07:00 , Oct 24, 2016 |  BC Week In Review  |  Financial News

Myovant amends IPO

Myovant Sciences Ltd. , Hamilton, Bermuda  Business: Genitourinary, Cancer, Endocrine/Metabolic  Date announced: 2016-10-17  Type: IPO  To be raised: Up to $195 million  Shares: 13 million  Price: $12-$15  Underwriters: Citigroup; Cowen; Evercore; Barclays Capital; JMP Securities;...